Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 25%
Buy 13%
Hold 50%
Sell 0%
Strong Sell 13%

Bulls say

Staar Surgical is well positioned for continued success with its dominant market position and innovative technology, as confirmed by ophthalmologists. The recent upgrade and raised price target reflect this potential, driven by strong Q1 results, optimism for a rebound in China, and successful new product launches. Additionally, the company's premium pricing for EVO+ should contribute to profitability.

Bears say

Staar Surgical is heavily reliant on its ICL products, which face stiff competition from corneal-based alternatives and laser procedures. While the company's ICL have a unique selling point of reversibility, its high cost and steep learning curve for doctors may hinder its adoption. Furthermore, the company's heavy reliance on foreign sales, particularly from China, presents a risk given geopolitical and macroeconomic uncertainties and the company's lack of formal revenue and earnings guidance.

STAAR Surgical (STAA) has been analyzed by 8 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 0% advise Selling, and 13% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 8 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Aug 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $28.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $28.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.